Safety of vasopressor use in head and neck microvascular reconstruction: A prospective observational study

Marcus M. Monroe, Steven B. Cannady, Tamer A. Ghanem, Christopher Swide, Mark Wax

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Objectives. To evaluate the safety of intraoperative vasopressor administration in a prospective series of patients undergoing free tissue transfer surgery for a variety of indications. Study Design. Prospective observational noninferiority study. Setting. Tertiary academic hospital. Subjects. A total of 169 consecutive patients undergoing free tissue transfer for a variety of indications between late 2007 and 2009. Methods. Intraoperative vasopressor use and surgical outcomes data were prospectively collected. This study was designed to test the noninferiority of intraoperative vasopressor exposure versus no intraoperative vasopressor use on early flap failure. Results. A total of 169 free flaps were performed during the study period. Six early free flap failures occurred overall. The proportion of patients experiencing early flap failure was 4.4% (4/90) in those exposed to intraoperative vasopressors versus 2.5% (2/79) in those not exposed, with an absolute difference of 1.9 percentage points (90% confidence interval, -1.4 to 5.2). Thirty-eight percent of patients in the vasopressor group experienced medical and/or surgical complications other than total flap loss versus 43% in the nonvasopressor group (odds ratio, 0.80; 95% confidence interval, 0.43-1.49). Conclusions. Intraoperative vasopressor use may be more common than previously realized in free tissue transfer surgery. Intraoperative vasopressor use does not result in a significant absolute increase in the rate of flap deaths.

Original languageEnglish (US)
Pages (from-to)877-882
Number of pages6
JournalOtolaryngology - Head and Neck Surgery
Volume144
Issue number6
DOIs
StatePublished - Jun 2011

Fingerprint

Observational Studies
Neck
Head
Prospective Studies
Safety
Free Tissue Flaps
Confidence Intervals
Tertiary Care Centers
Odds Ratio
Mortality

Keywords

  • Cancer
  • Ephedrine
  • Free flap
  • Free tissue transfer
  • Head and neck reconstruction
  • Microvascular
  • Papaverine
  • Phenylephrine
  • Squamous cell carcinoma
  • Vasoactive
  • Vasopressor

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Surgery
  • Medicine(all)

Cite this

Safety of vasopressor use in head and neck microvascular reconstruction : A prospective observational study. / Monroe, Marcus M.; Cannady, Steven B.; Ghanem, Tamer A.; Swide, Christopher; Wax, Mark.

In: Otolaryngology - Head and Neck Surgery, Vol. 144, No. 6, 06.2011, p. 877-882.

Research output: Contribution to journalArticle

@article{98b5dff2069d4d98bbb9a01dd5e84596,
title = "Safety of vasopressor use in head and neck microvascular reconstruction: A prospective observational study",
abstract = "Objectives. To evaluate the safety of intraoperative vasopressor administration in a prospective series of patients undergoing free tissue transfer surgery for a variety of indications. Study Design. Prospective observational noninferiority study. Setting. Tertiary academic hospital. Subjects. A total of 169 consecutive patients undergoing free tissue transfer for a variety of indications between late 2007 and 2009. Methods. Intraoperative vasopressor use and surgical outcomes data were prospectively collected. This study was designed to test the noninferiority of intraoperative vasopressor exposure versus no intraoperative vasopressor use on early flap failure. Results. A total of 169 free flaps were performed during the study period. Six early free flap failures occurred overall. The proportion of patients experiencing early flap failure was 4.4{\%} (4/90) in those exposed to intraoperative vasopressors versus 2.5{\%} (2/79) in those not exposed, with an absolute difference of 1.9 percentage points (90{\%} confidence interval, -1.4 to 5.2). Thirty-eight percent of patients in the vasopressor group experienced medical and/or surgical complications other than total flap loss versus 43{\%} in the nonvasopressor group (odds ratio, 0.80; 95{\%} confidence interval, 0.43-1.49). Conclusions. Intraoperative vasopressor use may be more common than previously realized in free tissue transfer surgery. Intraoperative vasopressor use does not result in a significant absolute increase in the rate of flap deaths.",
keywords = "Cancer, Ephedrine, Free flap, Free tissue transfer, Head and neck reconstruction, Microvascular, Papaverine, Phenylephrine, Squamous cell carcinoma, Vasoactive, Vasopressor",
author = "Monroe, {Marcus M.} and Cannady, {Steven B.} and Ghanem, {Tamer A.} and Christopher Swide and Mark Wax",
year = "2011",
month = "6",
doi = "10.1177/0194599811401313",
language = "English (US)",
volume = "144",
pages = "877--882",
journal = "Otolaryngology - Head and Neck Surgery (United States)",
issn = "0194-5998",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Safety of vasopressor use in head and neck microvascular reconstruction

T2 - A prospective observational study

AU - Monroe, Marcus M.

AU - Cannady, Steven B.

AU - Ghanem, Tamer A.

AU - Swide, Christopher

AU - Wax, Mark

PY - 2011/6

Y1 - 2011/6

N2 - Objectives. To evaluate the safety of intraoperative vasopressor administration in a prospective series of patients undergoing free tissue transfer surgery for a variety of indications. Study Design. Prospective observational noninferiority study. Setting. Tertiary academic hospital. Subjects. A total of 169 consecutive patients undergoing free tissue transfer for a variety of indications between late 2007 and 2009. Methods. Intraoperative vasopressor use and surgical outcomes data were prospectively collected. This study was designed to test the noninferiority of intraoperative vasopressor exposure versus no intraoperative vasopressor use on early flap failure. Results. A total of 169 free flaps were performed during the study period. Six early free flap failures occurred overall. The proportion of patients experiencing early flap failure was 4.4% (4/90) in those exposed to intraoperative vasopressors versus 2.5% (2/79) in those not exposed, with an absolute difference of 1.9 percentage points (90% confidence interval, -1.4 to 5.2). Thirty-eight percent of patients in the vasopressor group experienced medical and/or surgical complications other than total flap loss versus 43% in the nonvasopressor group (odds ratio, 0.80; 95% confidence interval, 0.43-1.49). Conclusions. Intraoperative vasopressor use may be more common than previously realized in free tissue transfer surgery. Intraoperative vasopressor use does not result in a significant absolute increase in the rate of flap deaths.

AB - Objectives. To evaluate the safety of intraoperative vasopressor administration in a prospective series of patients undergoing free tissue transfer surgery for a variety of indications. Study Design. Prospective observational noninferiority study. Setting. Tertiary academic hospital. Subjects. A total of 169 consecutive patients undergoing free tissue transfer for a variety of indications between late 2007 and 2009. Methods. Intraoperative vasopressor use and surgical outcomes data were prospectively collected. This study was designed to test the noninferiority of intraoperative vasopressor exposure versus no intraoperative vasopressor use on early flap failure. Results. A total of 169 free flaps were performed during the study period. Six early free flap failures occurred overall. The proportion of patients experiencing early flap failure was 4.4% (4/90) in those exposed to intraoperative vasopressors versus 2.5% (2/79) in those not exposed, with an absolute difference of 1.9 percentage points (90% confidence interval, -1.4 to 5.2). Thirty-eight percent of patients in the vasopressor group experienced medical and/or surgical complications other than total flap loss versus 43% in the nonvasopressor group (odds ratio, 0.80; 95% confidence interval, 0.43-1.49). Conclusions. Intraoperative vasopressor use may be more common than previously realized in free tissue transfer surgery. Intraoperative vasopressor use does not result in a significant absolute increase in the rate of flap deaths.

KW - Cancer

KW - Ephedrine

KW - Free flap

KW - Free tissue transfer

KW - Head and neck reconstruction

KW - Microvascular

KW - Papaverine

KW - Phenylephrine

KW - Squamous cell carcinoma

KW - Vasoactive

KW - Vasopressor

UR - http://www.scopus.com/inward/record.url?scp=79961183214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79961183214&partnerID=8YFLogxK

U2 - 10.1177/0194599811401313

DO - 10.1177/0194599811401313

M3 - Article

C2 - 21493297

AN - SCOPUS:79961183214

VL - 144

SP - 877

EP - 882

JO - Otolaryngology - Head and Neck Surgery (United States)

JF - Otolaryngology - Head and Neck Surgery (United States)

SN - 0194-5998

IS - 6

ER -